As previously discussed, Cel-Sci is in the final stages of a global Phase III trial testing the effectiveness of its lead product candidate, Multikine, in the treatment of head and neck cancer.  You can click HERE for my previous blog posts on the subject or scroll down the home page, if you'd like.  Although the share price and trading volume has somewhat stagnated through the summer months - as short interest continued to increase - a few items of interest are coming up that could reinvigorate life into CVM trading action...

Click "Read more" below to read more!

Read more